SavedAdd your journal

Journals / Genel Tıp Dergisi / 2004 / Cilt: 14 - Sayı: 4

The role of IGF and IGFBP in distinguishing malign-nonmalign pleural effusion

Malign-nonmalign plevral efüzyon ayırıcı tanısında IGF ve IGFBP’lerin rolü

Yavuz T. GEDERET
BAHADIR ÖZTÜRK
Emrah KARAGÖZOĞLU
Mehmet GÖK
A. Muhtar TİFTİK
Pages
139–143
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

IGF-II that has important effects on malignancy showed significant increase in pleural fluid than sera.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: IGF’s are polypeptides those mediates peripheral effects of GH.
📊
Key Findings & Data:IGF’s have important roles in cell proliferation and growth.
💡
Conclusion & Impact:IGF-II that has important effects on malignancy showed significant increase in pleural fluid than sera.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İnsülin-benzeri büyüme faktörü bağlayıcı proteinler · Akciğer neoplazmları · Plevral efüzyon

Abstract

Objective: IGF’s are polypeptides those mediates peripheral effects of GH. IGF’s have important roles in cell proliferation and growth. Also recent studies show IGF’s have important roles in malign proliferation. In this study it was aimed to investigate IGF’s and binding protein’s levels in lung carcinoma and nonspecific pleuritis. Methods: Patients which have pleural effusion, caused by different effects, were taken to this study. Patients were divided into two groups by their diagnosis; 20 were lung cancer, 20 were nonspecific pleuritis. Pleural fluids and seras were taken from patients to determine IGF-I-II and IGFBP I-II levels. Results: In malignancy patients, sera’s IGFBP-I and II levels were increased although it was not significant and pleural fluid’s IGFBP-I levels were significantly decreased and IGFBP-II levels were significantly increased. Sera’s and pleural fluid’s IGF-II levels significantly increased than the other group. The malignancy patient’s pleural fluid’s IGF-I levels were found significantly increased. Conclusion: Binding proteins that mediate the effects of IGF were increased in patients with malignancy. Binding proteins showed differences in pleural fluid of the patients. IGF-II that has important effects on malignancy showed significant increase in pleural fluid than sera.

Özet

Amaç: IGF’ler, Büyüme Hormonunun (GH) periferik etkilerine aracılık eden polipeptidlerdir. IGF’lerin, hücre büyümesi ve proliferasyonunda önemli etkileri vardır. Son yıllarda yapılan çalışmalarda IGF’lerin malign proliferasyonda da rolleri olduğu ortaya çıkmıştır. Çalışmamızda IGF ve bağlayıcı proteinlerin akciğer kanseri ve nonspesifik plöritiste seviyeleri ve malignite ile ilişkisi araştırıldı. Yöntem: Bu çalışmaya değişik nedenli plevral efüzyonu bulunan toplam 40 hasta alındı. Hastalar, konulan tanılara göre akciğer kanseri ve nonspesifik plörezi şeklinde iki gruba ayrıldı. Her bir grupta 20 hasta vardı. Bu hastalardan alınan serum ve plevral sıvı örneklerinde IGF I-II, IGFBP I-II analizleri yapıldı. Bulgular: Serumda IGFBP-I ve IGFBP-II, malign grupta anlamlı olmasa da yüksek iken, plevral sıvıda IGFBP-I düşük, IGFBP-II ise yüksek bulundu. Serum IGF-II ve plevral sıvı IGF-II seviyesi malign grupta anlamlı şekilde yüksek bulundu. Plevral sıvı IGF-I seviyesi malign grupta anlamlı şekilde yüksek bulundu. Sonuç: IGF’lerin etkilerine aracılık eden bağlayıcı proteinlerin malignitede yükseldiğini, plevral sıvı değerleri açısından da farklılık gösterdiğini tespit ettik. Malignitede özellikle etkili olan IGF-II ise plevral sıvıda, serumdan daha belirgin olarak yükselmektedir.

🔖

Cite This Article

GEDERET, Y. T., ÖZTÜRK, B., KARAGÖZOĞLU, E., GÖK, M., TİFTİK, A. M. (2004). The role of IGF and IGFBP in distinguishing malign-nonmalign pleural effusion. Genel Tıp Dergisi, Cilt: 14 - Sayı: 4, 139–143. https://ajindex.com/articles/224979

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Frohman LA. Disease of anterior pituitary. In: Frohman LA, editor. Endocrinology and Metabolism. Second ed. Mc Graw Hill Company 1987:265-6
  2. Whitley RJ, Meikle AW, Watts NB. Pituitery Function. In: Burtis CA, Ashwood ER, editors. Tietz Fundamentals of Clinical Chemistry. Fourth edition, Philadelphia: W.B.Saunders Company 1996:626-61
  3. Raizada M. Molecular Biology and Physiology of Insulin and Insulin-Like Growth Factors. Plenum Press, New York;1991:493-5
  4. Lowe WL. Insulin-like growth factors: Molecular and celluler aspect. In: LeRoith D, ed. Boca Raton: CRC Press Inc.; 1991:49-50
  5. Rechler MM, Nissley SP. Insulin-Like Growth Factor. In: Sporn MB, editors. Peptide Growth Factors and Their Receptors I. New York: Springer-Verlag; 1991:263-6
  6. Clemmons DR. Peptide growth factors. In: Kahn CR, Gordon CW, editors. Joslin’s Diabetes Mellitus. 13th ed. Philadelphia: A Waverly Company; 1994:177-92
  7. Baykal Y, Kılınç R, Kutlu M. İnsülin benzeri büyüme faktörleri ve reseptörleri. Sendrom 1998;10:77-87
  8. Lehninger AL. Hormones. In: Nelson DL, ed. Principles of Biochemistry. New York: Worth Publ; 1982:737-8
  9. Wu X, Yu H, Amos C, Hong W, Spitz M. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J National Cancer Inst 2000;92:737-43
  10. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65:311-20
  11. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocrinology Review 1995;16:3-18
  12. Edward G. Insulin-like growth factor-I and their binding protein–3 and risk of cancer. Hormone Research 1999;51:34- 41
  13. Havemann K, Rotsch M, Schöneberger HJ, Erbil C, Hennig C, Jagues G. Growth regulation by insulin-like growth factors in lung cancer. J Steroid Biochem Molec Biol 1990;37:877-82
  14. Jaques G, Rotsch M, Wegmann C, Worsch U, Maasberg M, Havemann K. Production of immunoreactive insulin-like growth factor I and response to exogenous IGF-I in small cell lung cancer cellines. Expl Cell Res 1998;176:336-43
  15. Yu H, Spitz R.M, Mistry J, Gu J, Hong WK, Wu X. Plasma Levels of insulin-like growth factor I and lung cancer risk: A case control analysis. J National Cancer Inst 1999;91:151-6
  16. Küçükusta AR. Solunum yollarının ve akciğerin enfeksiyon hastalıkları. İstanbul: Nobel Kitabevi; 2002:389-90
  17. Strom EH, Skjorten F, Aarseth LB, Haug E. Solitary fibrous tumor of the pleura: An immunohistochemical, electron microscopic and tissue culture